Corticotropin releasing factor and drug seeking in substance use disorders: Preclinical evidence and translational limitations
{{output}}
The neuropeptide, corticotropin releasing factor (CRF), has been an enigmatic target for the development of medications aimed at treating stress-related disorders. Despite a large body of evidence from preclinical studies in rodents demonstrating that CRF rece... ...
